Loading clinical trials...
Loading clinical trials...
The objective of the current study is to assess the impact of a five-week digital heart rate variability biofeedback (HRV-B) intervention or music listening on the well-being of first episode psychosi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The University of Hong Kong
NCT06650943 · First Episode Psychosis (FEP), Metabolic Syndrome X
NCT04007510 · First Episode Psychosis (FEP)
NCT05509998 · First Episode Psychosis (FEP), Clinical High Risk for Psychosis (CHR)
NCT07245212 · Psychosis, Cannabis Use Disorder, and more
NCT07196423 · First Episode Psychosis (FEP), Psychosis
Queen Mary Hospital/University of Hong Kong
Hong Kong, SAR China
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions